News

Antipsychotics’ risk in dementia revised upward


 

AT THE AAGP ANNUAL MEETING

Dr. Maust’s study was sponsored by the National Institute of Mental Health and the University of Michigan Program for Positive Aging. He reported having no financial conflicts, as did Dr. Lee, whose study was unfunded.

bjancin@frontlinemedcom.com

Pages

Recommended Reading

Glycerol phenylbutyrate reduces hepatic encephalopathy events in cirrhosis
MDedge Internal Medicine
Two definitions of Gulf War illness recommended
MDedge Internal Medicine
USPSTF: Evidence still ‘insufficient’ to back cognitive impairment screening
MDedge Internal Medicine
Hoarding: Not just a symptom of OCD
MDedge Internal Medicine
Late-life depression can be dementia prodrome
MDedge Internal Medicine
Say goodbye to ‘dementia’
MDedge Internal Medicine
ECT quells dementia-associated agitation
MDedge Internal Medicine
Simple smell test may predict donepezil response
MDedge Internal Medicine
Human brain mapping project begins to reveal roots of developmental abnormalities
MDedge Internal Medicine
Depression at least five times more common than PTSD after critical illness
MDedge Internal Medicine